Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 124-131

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1225-1230

Bentham Science Publishers

Access to resources Recommend Favorite

Role of oxaliplatin in colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Anti-EGFR Strategy for Colorectal Cancer: Searching for the Real Target

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 8, 2006-10 ,pp. : 541-543

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 68-79

Bentham Science Publishers

Access to resources Recommend Favorite